Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

2016

Appendix 4G and Corporate Governance Statement

8 August 2016 by Audrey Thomson

Appendix 4G and Corporate Governance Statement

Categories 2016, ASX Announcements

New Issue Announcement – Appendix 3B

15 July 2016 by Audrey Thomson

New Issue Announcement Appendix 3B

Categories 2016, ASX Announcements

Appendix 4C

8 July 2016 by Audrey Thomson

Appendix 4C

Categories 2016, ASX Announcements

New Issue Announcement – Appendix 3B

7 July 2016 by Audrey Thomson

New Issue Announcement – Appendix 3B

Categories 2016, ASX Announcements

Biotron Compounds Demonstrate Activity Against Zika Virus

29 November 201623 May 2016 by Justine Bednorz

Biotron Compounds Demonstrate Activity Against Zika Virus

Categories 2016, ASX Announcements

Presentation at Biotech Invest 2016

29 November 20164 May 2016 by Audrey Thomson

Presentation at Biotech Invest 2016

Categories 2016, ASX Announcements

R&D Tax Incentive

29 November 201620 April 2016 by Audrey Thomson

R&D Tax Incentive

Categories 2016, ASX Announcements

Appendix 4C

20 April 2016 by Audrey Thomson

Appendix 4C

Categories 2016, ASX Announcements

Shareholder Update

12 April 2016 by Audrey Thomson

Shareholder Update

Categories 2016, ASX Announcements

Biotron Phase 2 Hepatitis C Trial Success

17 March 2016 by Audrey Thomson

Biotron Phase 2 Hepatitis C Trial Success

Categories 2016, ASX Announcements
Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 25 June 2025        Legal Notices and Privacy
Cleantalk Pixel